TMS for Complex Regional Pain Syndrome

Part of paid clinical trials in Redwood City, California.

Sponsor
Stanford University
Study ID
NCT03137472
Status
Recruiting
Apply to this trial

Conditions

  • Complex Regional Pain Syndromes

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • Transcranial Magnetic Stimulation (TMS) — DEVICE
    The Magventure TMS stimulator will be used to perform intermittent theta burst followed by high frequency Transcranial Magnetic Stimulation (TMS).

Study Details

The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline. Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.

Key Dates

Start date
Apr 24, 2017
Status verified
May 2025
Primary completion
Jun 29, 2026
Completion
Jun 29, 2026

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Active Treatment
    Participants will receive active TMS in the target area once daily for two days
  • Sham Comparator: Sham Treatment
    Participants will receive active TMS in a non-target area once daily for two days

Primary Outcome Measure

Change in Pain [ Time Frame: 1 week follow-up compared to baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford Pain Management CenterRedwood CityCalifornia94043
Birute Gedrimaite
[email protected]
650-497-0485

Find similar trials in Redwood City, CA

By research site
Stanford Pain Management Center· Redwood City, CA

Related Studies